Candel Therapeutics (CADL) Current Assets: 2020-2023
Historic Current Assets for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $45.1 million.
- Candel Therapeutics' Current Assets fell 42.96% to $45.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $45.1 million, marking a year-over-year decrease of 42.96%. This contributed to the annual value of $71.9 million for FY2022, which is 15.30% down from last year.
- Per Candel Therapeutics' latest filing, its Current Assets stood at $45.1 million for Q3 2023, which was down 15.48% from $53.4 million recorded in Q2 2023.
- Candel Therapeutics' Current Assets' 5-year high stood at $95.6 million during Q1 2022, with a 5-year trough of $24.4 million in Q2 2021.
- In the last 3 years, Candel Therapeutics' Current Assets had a median value of $75.5 million in 2022 and averaged $69.5 million.
- As far as peak fluctuations go, Candel Therapeutics' Current Assets soared by 257.51% in 2022, and later tumbled by 42.96% in 2023.
- Over the past 4 years, Candel Therapeutics' Current Assets (Quarterly) stood at $35.1 million in 2020, then skyrocketed by 141.69% to $84.9 million in 2021, then dropped by 15.30% to $71.9 million in 2022, then plummeted by 42.96% to $45.1 million in 2023.
- Its Current Assets stands at $45.1 million for Q3 2023, versus $53.4 million for Q2 2023 and $61.9 million for Q1 2023.